For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Supernus Pharmaceuticals Inc (NASDAQ: SUPN) closed at $30.94 down -4.59% from its previous closing price of $32.43. In other words, the price has decreased by -$4.59 from its previous closing price. On the day, 1.07 million shares were traded.
Ratios:
For a deeper understanding of Supernus Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.74 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.61. For the most recent quarter (mrq), Quick Ratio is recorded 2.26 and its Current Ratio is at 2.44. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cantor Fitzgerald on February 19, 2025, Downgraded its rating to Neutral and sets its target price to $36 from $57 previously.
On January 06, 2025, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $57.
Piper Sandler Downgraded its Overweight to Neutral on September 11, 2024, whereas the target price for the stock was revised from $41 to $36.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 21 ’25 when Rubin Jonathan sold 927 shares for $39.15 per share. The transaction valued at 36,292 led to the insider holds 7,853 shares of the business.
Bhatt Padmanabh P. sold 9,477 shares of SUPN for $376,237 on Feb 04 ’25. The Sr. VP of IP, CSO now owns 10,149 shares after completing the transaction at $39.70 per share. On Jan 27 ’25, another insider, Bhatt Padmanabh P., who serves as the Sr. VP of IP, CSO of the company, sold 2,573 shares for $39.62 each. As a result, the insider received 101,942 and left with 10,149 shares of the company.
Valuation Measures:
As of this moment, Supernus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 28.02, and their Forward P/E ratio for the next fiscal year is 11.95. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 12.79. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.59 while its Price-to-Book (P/B) ratio in mrq is 1.68.
Stock Price History:
Over the past 52 weeks, SUPN has reached a high of $40.28, while it has fallen to a 52-week low of $25.53. The 50-Day Moving Average of the stock is -3.05%, while the 200-Day Moving Average is calculated to be -9.20%.
Shares Statistics:
A total of 55.99M shares are outstanding, with a floating share count of 53.51M. Insiders hold about 4.43% of the company’s shares, while institutions hold 105.78% stake in the company.
